The Standard for Critical Environment Safety
Contamination is not an acceptable risk. Delox develops proprietary bio-decontamination solutions where the margin for error is zero.
Contamination is not an acceptable risk. Delox develops proprietary bio-decontamination solutions where the margin for error is zero.
Delox is an international technology company developing advanced bio-decontamination solutions for the world’s most demanding environments.
Our work sits at the intersection of chemistry, biochemistry, and materials science, where precision is not optional and the margin for error is zero.
With an active presence across Europe and North America, and backed by institutional investors and long-term strategic partners, Delox is positioned to lead the next generation of contamination control solutions on a global scale.
To make critical environments safer, through rigorous science, proprietary technology, and an unwavering commitment to precision.
The world faces growing challenges in contamination control. Antimicrobial resistance, healthcare-associated infections, and constantly evolving regulatory demands are pressuring organizations worldwide to do more, and to do it better.
Delox exists to meet that pressure. Not with generic solutions, but with technology developed specifically for contexts where failure is not an option.
Our approach begins in science and ends in the field. We have developed a proprietary solid hydrogen peroxide technology – a platform that enables controlled, residue-free decontamination with proven efficacy, tailored to the real complexity of healthcare, pharmaceutical, laboratory, and industrial settings.
We don’t sell products. We build partnerships with organizations operating in highly controlled environments that need a technical partner they can rely on. Today and in the future.
Delox was founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, born from years of academic research at the intersection of chemistry, biochemistry, and materials science.
What began as a scientific question about whether nanoporous materials could be used to control the release of hydrogen peroxide led to the development of DeloxHP, a proprietary technology of solid formulation of hydrogen peroxide technology.
From university lab to global operations, Delox has grown into an international platform for advanced bio-decontamination, operating across Europe and North America and backed by institutional investors and strategic partners. The science has always been the foundation. The mission is what drives us forward.